Differentiation between Thyroidal and Ectopic Calcitonin Secretion in patients with Coincidental Thyroid Nodules and Pancreatic Tumors – A Report of Two Cases

Abstract

Although elevated blood levels of calcitonin are considered highly indicative for the presence of medullary thyroid carcinomas, they may be observed in patients with chronic kidney disease or in consequence of ectopic calcitonin production. We report two patients who presented with excessively elevated calcitonin levels. Diagnostic work-up revealed a single thyroid nodule and a pancreatic tumor with ectopic calcitonin secretion in both of them. On the basis of these case reports, the diagnostic work flow and management in case of clearly elevated calcitonin levels are described and discussed.

Key words

calcitonin - pancreatic endocrine tumor - secondary hyperparathyroidism - medullary thyroid carcinoma - chronic kidney disease

References

• 1 Hirsch PF, Lester GE, Talmage RV. Calcitonin, an enigmatic hormone: does it have a function?.  J Musculoskel Neuron Interact. 2001;  1 299-305
• 2 Constante G, Meringolo D, Durante C. et al . Predictive value of serum calcitonin levels for preoperative diagnosis of medullary thyroid carcinoma in a cohort of 5817 consecutive patients with thyroid nodules.  J Clin Endocrinol Metab. 2007;  92 450-455
• 3 Pacini F, Schlumberger M, Dralle H. et al . , The European Thyroid Cancer Taskforce Consensus for the management of patients with differentiated thyroid carcinoma of the follicular epithelium.  Eur J Endocrinol. 2006;  154 787-803
• 4 Roman SA, Mehta P, Sosa JA. Medullary thyroid cancer: early detection and novel treatments.  Curr Opin Oncol. 2008;  21 5-10
• 5 Mullerpatan PM, Joshi SR, Shah RC. et al . Calcitonin-secreting tumor of the pancreas.  Dig Surg. 2004;  21 321-324
• 6 Metz DC, Jensen RT. Gastrointestinal neuroendocrine tumors: pancreatic endocrine tumors.  Gastroenterology. 2008;  135 1469-1492
• 7 Öberg K, Eriksson B. Endocrine tumors of the pancreas.  Best Pract Res Clin Gastroenterol. 2005;  19 753-781
• 8 Jensen RT, Norton JA. Management of metastatic pancreatic endocrine tumors. In Feldman M, Scharschmidt BF, Sleisener MH (eds) Gastrointestinal and Liver Disease. Philadelphia, Saunders 1998 p 871
• 9 Weil C. Gastroenteropancreatic endocrine tumors.  Klin Wochenschr. 1985;  63 433-459
• 10 Eskens FA, Roclofs EJ, Hermus AR. et al . Pancreatic islet cell tumor producing vasoactive intestinal peptide and calcitonin.  Anticancer Res. 1997;  17 4667-4670
• 11 Howard JM, Gohara AF, Cardwell RJ. Malignant islet cell tumor of the pancreas associated with high plasma calcitonin and somatostatin levels.  Surgery. 1989;  105 227-229
• 12 Manche A, Wood SM, Adrian TE. et al . Pancreatic polypeptide and calcitonin secretion from a pancreatic tumor-clinical improvement after hepatic artery embolization.  Postgrad Med J. 1983;  59 313-314
• 13 Marty-Double C, Balmes P, Pignodel C. et al . Carcinoma of the pancreas with amyloid stroma and calcitonin secretion: Ultrastructural study.  Ann Pathol. 1981;  1 99-101
• 14 Asa SL, Kovacs K, Killinger DW. et al . Pancreatic islet cell carcinoma producing gastrin, ACTH, alpha-endorphin, somatostatin, and calcitonin.  Am J Gastroenterol. 1980;  74 30-35
• 15 Kaassis M, Duquenne M, Croue A. et al . Calcitonin-secreting neuroendocrine carcinoma of the pancreas with splenic invasion and paraneoplastic hypercalcaemia.  Presse Med. 2001;  30 24
• 16 Machens A, Haedecke J, Hinze R. et al . Hypercalcitoninemia in a sporadic asymptomatic neuroendocrine tumor of the pancreatic tail.  Dig Surg. 2000;  17 522-524
• 17 Fleury A, Flejou JF, Sauvanet A. et al . Calcitonin-secreting tumors of the pancreas: About six cases.  Pancreas. 1998;  16 545-550
• 18 Delis S, Bakoyiannis A, Giannakou N. et al . Asymptomatic calcitonin-secreting tumor of the pancreas – a case report.  JOP. 2006;  7 70-73
• 19 Raue F, Zinke A, Scherübl H. Regulation of calcitonin secretion and calcitonin gene expression.  Recent Results in Cancer Research. 1992;  125 1-18
• 20 Calmettes C, Chaventre A, Feingold N. et al . Screening for medullary thyroid cancer in France. A national effort.  Henry Ford Hosp Med J. 1989;  37 120-121
• 21 Cheung KC, Roman SA, Wang TS. et al . Calcitonin measurement in the evaluation of thyroid nodules in the United States: a cost-effectiveness and decision analysis.  J Clin Endocrinol Metab. 2008;  93 2173-2180
• 22 Pacini F, Fontanelli M, Fugazzola L. et al . Routine measurement of serum calcitonin in nodular thyroid disease allows the preoperative diagnosis of unsuspected sporadic medullary thyroid carcinoma.  J Clin Endocrinol Metab. 1994;  78 826-829
• 23 Rieu M, Lane MC, Richard A. et al . Prevalence of sporadic medullary thyroid carcinoma. The importance of routine measurements of serum calcitonin in the diagnostic evaluation of thyroid nodules.  Clin Endocrinol. 1995;  42 453-460
• 24 Vierhapper H, Raber W, Biegelmayer C. et al . Routine measurements of plasma calcitonin in nodular thyroid diseases.  J Clin Endocrinol Metab. 1997;  82 1589-1593
• 25 Cheung KC, Roman SA, Wang TS. et al . Calcitonin measurement in the evaluation of thyroid nodules in the United States: a cost-effectiveness and decision analysis.  J Clin Endocrinol Metab. 2008;  93 2173-2180
• 26 Roman SA, Lin R, Sosa JA. Prognosis of medullary thyroid carcinoma.  Cancer. 2006;  107 2134-2142
• 27 Lamp EJ, Heddle RM, Ellis A. Spuriously elevated plasma calcitonin in a patient with a thyroid nodule not associated with medullary thyroid carcinoma.  Postgrad Med J. 1999;  75 289-291
• 28 Demers LM, Spencer CA. Laboratory medicine practice guidelines. Laboratory support for the diagnosis and monitoring of thyroid disease.  Thyroid. 2003;  13 4-126
• 29 Vitale G, Ciccarelli A, Caraglia M. et al . Comparison of two provocative tests for calcitonin in medullary thyroid carcinoma: omeprazole vs calcitonin.  Clinical Chemistry. 2002;  48 1505-1510
• 30 Iacobone M, Niccoli-Sire P, Sebag F. et al . Can sporadic medullary thyroid carcinoma be biochemically predicated? Prospective analysis of 66 operated patients with elevated serum calcitonin levels.  World J Surg. 2002;  26 886-890
• 31 Leboulleux S, Baudin E, Travagli JP. et al . Medullary Thyroid Carcinoma: Secretory Products. http://www.medscape.com/viewarticle/489038_5
• 32 Lissak B, Baudin E, Cohen R. et al . Pentagastrin testting in patients with renal insufficiency: normal responsivity of mature calcitonin.  Thyroid. 1998;  8 265-268
• 33 Kotzmann H, Schmidt A, Scheuba C. et al . Basal calcitonin levels and response to pentagastrin stimulation in patients after kidney transplantation or on chronic hemodialysis as indicators of medullary carcinoma.  Thyroid. 1999;  9 943-947
• 34 Niccoli P, Brunet P, Roubicek C. et al . Abnormal calcitonin levels and pentagastrin response in patients with chronic renal failure on maintenance hemodialysis.  Eur J Endocrinol. 1995;  132 75-81
• 35 Felsenfeld AJ, Machado L, Rodriguez M. The relationship between serum calcitonin and serum calcium in hemodialysis patients.  Am J Kidney Dis. 1993;  21 292-299
• 36 Tomita T, Millard DM. C-cell hyperplasia in secondary hyperparathyroidism.  Histopathology. 1992;  21 46974
• 37 Simmons RE, Hjelle JT, Mahoney C. et al . Renal metabolism of calcitonin.  Am J Physiol. 1988;  254 593-600
• 38 Gibson WGH, Peng T, Croker BP. Age associated C-cell hyperplasia in the human thyroid.  Am J Physiol. 1982;  106 388-393
• 39 Guyetant S, Wion-Barbot N, Rousselet M. et al . C-cell hyperplasia associated with chronic lymphocytic thyroiditis.  Hum Pathol. 1994;  25 514-521
• 40 Engelbach M, Heerdt S, Görges R. et al . Is there an ectopic secretion of monomeric calcitonin in the human being?.  Arch Surg. 1998;  383 456-459
• 41 Ichimura T, Kondo S, Okushiba S. et al . A calcitonin and vasoactive intestinal peptide producing pancreatic endocrine tumor associated with WDHA syndrome.  Int J Gastrointest Cancer. 2003;  33 99-102

Correspondence